Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 7/2013

01-07-2013 | Letters

Community-Acquired Pneumonia and Proton Pump Inhibitors

Authors: Matthew A. Rysavy, BS, Eric Ammann, MS, Ryan Carnahan, PharmD

Published in: Journal of General Internal Medicine | Issue 7/2013

Login to get access

Excerpt

To the Editors:—We read with interest the article by Jena and colleagues regarding the possibility of residual confounding in the association of proton pump inhibitors (PPIs) and community-acquired pneumonia (CAP).1 Specifically, we appreciated the argument for “falsification analysis,” which Jena has discussed elsewhere.2 …
Literature
1.
Jena AB, Sun E, Goldman DP. Confounding in the association of proton pump inhibitor use with risk of community-acquired pneumonia. JGIM. 2012;28(2):223–30.PubMedCrossRef
2.
Prasad V, Jena AB. Prespecified falsification end points: can they validate true observational associations? JAMA. 2013;309(3):241–2.PubMedCrossRef
3.
Weiss NS. Can the “specificity” of an association be rehabilitated as a basis for supporting a causal hypothesis? Epidemiology. 2002;13:6–8.PubMedCrossRef
4.
Rothman KJ, Greenland S. Causation and causal inference in epidemiology. Am J Public Health. 2005;95(S1):S144–50.PubMedCrossRef
5.
Giuliano C, Wilhelm SM, Kale-Pradhan PB. Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis. Expert Rev Clin Pharmacol. 2012;5(3):337–44.PubMedCrossRef
Metadata
Title
Community-Acquired Pneumonia and Proton Pump Inhibitors
Authors
Matthew A. Rysavy, BS
Eric Ammann, MS
Ryan Carnahan, PharmD
Publication date
01-07-2013
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 7/2013
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-013-2432-2

Other articles of this Issue 7/2013

Journal of General Internal Medicine 7/2013 Go to the issue

Letters

Community-Acquired Pneumonia and Proton Pump Inhibitors

Original Research

Access, Interest, and Attitudes Toward Electronic Communication for Health Care Among Patients in the Medical Safety Net

Healing Arts: Materia Medica

Team Player

Original Research

Statin Use and Clinical Osteoarthritis in the General Population: A Longitudinal Study

Erratum

Erratum to: Risk Factors for Nosocomial Gastrointestinal Bleeding and Use of Acid-Suppressive Medication in Non-Critically Ill Patients

Health Policy

Variation in Electronic Health Record Adoption and Readiness for Meaningful Use: 2008–2011
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits